NORJAN FAYE TOMAWIS: Open Payments
NPI 1487369989 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,338 in 57 payments from 20 companies in 2025. Trend: 2023 $550 · 2024 $1,653 · 2025 $1,338
Food & beverage: $1,238Education: $100
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $280 |
| Janssen Biotech, Inc. | 3 | $249 |
| ABBVIE INC. | 7 | $146 |
| Novartis Pharmaceuticals Corporation | 6 | $126 |
| PFIZER INC. | 4 | $98 |
| UCB, Inc. | 3 | $64 |
| SOBI, INC | 2 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| TerSera Therapeutics LLC | 2 | $38 |
| ANI Pharmaceuticals, Inc. | 1 | $29 |
Products named: TREMFYA, ENBREL, RINVOQ, COSENTYX, TAVNEOS, Bimzelx, XELJANZ, OCTAGAM IMMUNE GLOBULIN (HUMAN).
Industry payments across VA — which companies pay providers there.
